EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Engineering Immune Cell to Counteract Aging and Aging‐Associated Diseases

Jianhua Guo, Lanjie Lei, Ying Jin, Lan Su, Shumao Cui, Liyun Shi iD

Advanced Science · 2026

DOI: 10.1002/advs.202521776 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, 2026. Verfasst von Jianhua Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key lab of Artificial Organs and Computational Medicine, Institute of Translational Medicine, Zhejiang Shuren University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Aging, Immunotherapy, Autoimmune Diseases, Immune System. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 224 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Scientific Funds, Zhejiang Shuren University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging and age‐related diseases are a major public health concern, driving interest in anti‐aging research. While small molecules and natural compounds show promise in animals, clinical translation is limited. Recently, chimeric antigen receptor (CAR)‐engineered immune cells have achieved breakthroughs in treating non‐cancerous conditions like autoimmune diseases and organ fibrosis, highlighting their therapeutic potential. This review explains how the immune system counteracts aging through senescent cell clearance, reduction of pro‐inflammatory environments, and secretion of regenerative factors. It synthesizes principles of immune cell‐based anti‐aging therapies, analyzing preclinical and clinical studies. Key challenges include limited target specificity, immunosuppressive microenvironments, and variability in cell source and function. Future progress will require multidisciplinary collaboration—incorporating nanotechnology, synthetic biology, and targeted delivery—with artificial intelligence accelerating the development of personalized anti‐aging interventions. Cellular immunotherapies thus hold transformative potential for modulating aging and advancing precision medicine to extend global healthspan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingImmunotherapyAutoimmune DiseasesImmune SystemHumansAnimalsCellular SenescenceReceptors, Chimeric Antigen

Stichwörter der Autor:innen

agingaging‐associated pathologiescellular immunotherapiesclinical translationmechanism exploration

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Key lab of Artificial Organs and Computational Medicine, Institute of Translational Medicine, Zhejiang Shuren University, Hangzhou, Zhejiang, China.
  • Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Department of Paediatrics & Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, China.

ORCID-Profile: Liyun Shi

Förderung

  • National Natural Scientific Funds
  • Zhejiang Shuren University

Zitieren

APA

Guo, J., Lei, L., Jin, Y., Su, L., Cui, S., & Shi, L. (2026). Engineering Immune Cell to Counteract Aging and Aging‐Associated Diseases. Advanced Science. https://doi.org/10.1002/advs.202521776

Vancouver

Guo J, Lei L, Jin Y, Su L, Cui S, Shi L. Engineering Immune Cell to Counteract Aging and Aging‐Associated Diseases. Advanced Science. 2026. doi:10.1002/advs.202521776

BibTeX
@article{Guo2026,
  author = {Guo, Jianhua and Lei, Lanjie and Jin, Ying and Su, Lan and Cui, Shumao and Shi, Liyun},
  title = {Engineering Immune Cell to Counteract Aging and Aging‐Associated Diseases},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202521776}
}
Kostenlos starten →